Meningioma diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{meningioma}} | {{meningioma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{IO}} | ||
== Overview == | == Overview == | ||
MRI is the gold standard test for the diagnosis of meningioma. | [[Magnetic resonance imaging|MRI]] is the [[Gold standard (test)|gold standard test]] for the [[diagnosis]] of meningioma. | ||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
=== Study of | === Study of Choice === | ||
MRI is the gold standard test for the diagnosis of meningioma. Regardless, CT is more widely available, better in urgent settings, and used when patients have a contraindication to MRI usage such as pacemakers.<ref name="pmid24399610">{{cite journal| author=Watts J, Box G, Galvin A, Brotchie P, Trost N, Sutherland T| title=Magnetic resonance imaging of meningiomas: a pictorial review. | journal=Insights Imaging | year= 2014 | volume= 5 | issue= 1 | pages= 113-22 | pmid=24399610 | doi=10.1007/s13244-013-0302-4 | pmc=3948902 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24399610 }} </ref><ref name="pmid28531331">{{cite journal| author=Nowosielski M, Galldiks N, Iglseder S, Kickingereder P, von Deimling A, Bendszus M et al.| title=Diagnostic challenges in meningioma. | journal=Neuro Oncol | year= 2017 | volume= 19 | issue= 12 | pages= 1588-1598 | pmid=28531331 | doi=10.1093/neuonc/nox101 | pmc=5716093 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28531331 }} </ref> | |||
* [[Magnetic resonance imaging|MRI]] is the [[Gold standard (test)|gold standard test]] for the [[diagnosis]] of meningioma. | |||
* Regardless, [[Computed tomography|CT scan]] is more widely available, better in urgent settings, and used when patients have a contraindication to [[Magnetic resonance imaging|MRI]] usage such as pacemakers.<ref name="pmid24399610">{{cite journal| author=Watts J, Box G, Galvin A, Brotchie P, Trost N, Sutherland T| title=Magnetic resonance imaging of meningiomas: a pictorial review. | journal=Insights Imaging | year= 2014 | volume= 5 | issue= 1 | pages= 113-22 | pmid=24399610 | doi=10.1007/s13244-013-0302-4 | pmc=3948902 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24399610 }} </ref><ref name="pmid28531331">{{cite journal| author=Nowosielski M, Galldiks N, Iglseder S, Kickingereder P, von Deimling A, Bendszus M et al.| title=Diagnostic challenges in meningioma. | journal=Neuro Oncol | year= 2017 | volume= 19 | issue= 12 | pages= 1588-1598 | pmid=28531331 | doi=10.1093/neuonc/nox101 | pmc=5716093 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28531331 }} </ref> | |||
==References== | ==References== |
Latest revision as of 20:13, 20 September 2019
Meningioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Meningioma diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Meningioma diagnostic study of choice |
Risk calculators and risk factors for Meningioma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ifeoma Odukwe, M.D. [2]
Overview
MRI is the gold standard test for the diagnosis of meningioma.
Diagnostic Study of Choice
Study of Choice
- MRI is the gold standard test for the diagnosis of meningioma.
- Regardless, CT scan is more widely available, better in urgent settings, and used when patients have a contraindication to MRI usage such as pacemakers.[1][2]
References
- ↑ Watts J, Box G, Galvin A, Brotchie P, Trost N, Sutherland T (2014). "Magnetic resonance imaging of meningiomas: a pictorial review". Insights Imaging. 5 (1): 113–22. doi:10.1007/s13244-013-0302-4. PMC 3948902. PMID 24399610.
- ↑ Nowosielski M, Galldiks N, Iglseder S, Kickingereder P, von Deimling A, Bendszus M; et al. (2017). "Diagnostic challenges in meningioma". Neuro Oncol. 19 (12): 1588–1598. doi:10.1093/neuonc/nox101. PMC 5716093. PMID 28531331.